Amplifyer Bio
Lexington, US · Founded 2023 · Delaware corporation · 10 employees on LinkedIn · 1 known investors
Amplifyer develops liquid biopsy technology aimed at improving outcomes for cancer patients. The company operates in the biotech and diagnostics space.
Founders & leadership
AM

Annie Murphyin
EK
Eric K. HuangNamed on SEC filing
JC
J. Christopher LoveNamed on SEC filing
VA
Viktor A. AdalsteinssonNamed on SEC filing
Board
TD

SL

Investors · 1
Reported raises · per SEC filings
Form D private placements$7.1M disclosed across 1 round · 2024
▶$7.1MraisedOct 2024 · 12 investors · BiotechnologyRule 506(b)
▶$7.1MraisedOct 2024 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eric K. HuangExecutive Officer, Director
- J. Christopher LoveDirector
- Thomas de VlaamDirector
- Viktor A. AdalsteinssonDirector
- Stanley LapidusDirector
- Offering amount
- $7.1M
- Amount sold
- $7.1M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Amplifyer Bio do?
- Amplifyer develops liquid biopsy technology aimed at improving outcomes for cancer patients. The company operates in the biotech and diagnostics space.
- Who are Amplifyer Bio's investors?
- Amplifyer Bio's investors include Pillar VC.
- How much funding has Amplifyer Bio raised?
- Amplifyer Bio has disclosed $7.1M raised across 1 round.
- Where is Amplifyer Bio headquartered?
- Amplifyer Bio is headquartered in Lexington, US.

